EXANE DERIVATIVES - TWIST BIOSCIENCE CORP ownership

TWIST BIOSCIENCE CORP's ticker is TWST and the CUSIP is 90184D100. A total of 209 filers reported holding TWIST BIOSCIENCE CORP in Q1 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of TWIST BIOSCIENCE CORP
ValueSharesWeighting
Q1 2022$177,362,000
-54.2%
3,592
-0.9%
0.05%
-46.2%
Q3 2021$387,538,000
-11.1%
3,6230.0%0.09%
-6.1%
Q2 2021$435,764,000
+109.6%
3,623
+115.8%
0.10%
+67.8%
Q1 2021$207,952,0001,6790.06%
Other shareholders
TWIST BIOSCIENCE CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Tao Capital Management LP 1,104,214$156,015,00038.36%
Blue Water Life Science Advisors, LP 146,356$20,678,0006.16%
Casdin Capital, LLC 1,000,000$141,290,0004.19%
BRANDYWINE MANAGERS, LLC 18,988$2,683,0003.69%
Capital Impact Advisors, LLC 97,000$13,705,0003.36%
Brevan Howard Capital Management LP 112,000$15,824,0003.17%
ARK Investment Management 5,876,971$830,357,0002.21%
Nicholas Investment Partners, LP 178,875$25,273,0001.95%
Nikko Asset Management Americas, Inc. 1,840,306$260,017,0001.48%
Intellectus Partners, LLC 28,058$3,964,0001.19%
View complete list of TWIST BIOSCIENCE CORP shareholders